ACG临床指南:异常肝脏生化指标的评估
本指南由美国胃肠病学会(ACG)制定,针对血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、碱性磷酸酶和胆红素等肝脏生化指标的异常评估提供指导。指南定义了肝细胞损伤和胆汁淤积性损伤,并提出了基于损伤类型的评估流程,包括病毒性肝炎、非酒精性脂肪性肝病、遗传代谢性疾病等检测,以及肝活检的考虑时机。
要点
- 肝细胞损伤定义为AST和ALT水平相较于碱性磷酸酶不成比例升高。
- 男性正常ALT水平为29-33 IU/L,女性为19-25 IU/L,高于此范围应评估。
- 碱性磷酸酶升高确定为肝源性时,应检测原发性胆汁性胆管炎和原发性硬化性胆管炎。
核心结论
- 指南对异常肝脏生化指标的评估提供了基于证据的推荐,包括定义肝细胞损伤和胆汁淤积性损伤,并建议根据ALT/AST升高程度指导评估。
研究设计与样本
- 本指南由美国胃肠病学会(ACG)制定,基于对现有证据的回顾,具体方法学未在摘要中详述。
主要发现
- 多项研究表明ALT升高与肝病相关死亡率增加有关。
- 真正的健康正常ALT水平男性为29-33 IU/L,女性为19-25 IU/L,高于此水平应进行评估。
- 肝细胞损伤的评估包括检测甲型、乙型和丙型病毒性肝炎,评估非酒精性脂肪性肝病和酒精性肝病,筛查遗传性血色病、自身免疫性肝炎、Wilson病和α-1抗胰蛋白酶缺乏症。
- 对于确定为肝源性的碱性磷酸酶升高,应检测原发性胆汁性胆管炎和原发性硬化性胆管炎。
- 总胆红素升高可发生于胆汁淤积性或肝细胞性疾病,血清结合胆红素升高提示肝细胞疾病或胆道梗阻。
关键数值与推荐
- 肝细胞损伤定义为AST和ALT水平相较于碱性磷酸酶不成比例升高。
- 胆汁淤积性损伤定义为碱性磷酸酶水平相较于AST和ALT不成比例升高。
- 男性正常ALT水平为29-33 IU/L,女性为19-25 IU/L,高于此范围应评估。
- 当血清学检测和影像学无法明确诊断、需对病情进行分期或存在多种可能诊断时,可考虑肝活检。
临床怎么用
- 临床医生应每日评估异常肝脏生化指标,包括ALT、AST、碱性磷酸酶和胆红素。
- 应根据ALT和/或AST升高程度指导评估,包括病毒性肝炎、非酒精性脂肪性肝病、酒精性肝病、遗传性血色病、自身免疫性肝炎、Wilson病和α-1抗胰蛋白酶缺乏症的检测。
- 应询问处方药和非处方药使用史。
- 对于肝源性碱性磷酸酶升高,应检测原发性胆汁性胆管炎和原发性硬化性胆管炎。
- 总胆红素升高应 fractionated 为直接和间接胆红素,血清结合胆红素升高提示肝细胞疾病或胆道梗阻。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is defined as disproportionate elevation of alkaline phosphatase level as compared with AST and ALT levels. The majority of bilirubin circulates as unconjugated bilirubin and an elevated conjugated bilirubin implies hepatocellular disease or cholestasis. Multiple studies have demonstrated that the presence of an elevated ALT has been associated with increased liver-related mortality. A true healthy normal ALT level ranges from 29 to 33 IU/l for males, 19 to 25 IU/l for females and levels above this should be assessed. The degree of elevation of ALT and or AST in the clinical setting helps guide the evaluation. The evaluation of hepatocellular injury includes testing for viral hepatitis A, B, and C, assessment for nonalcoholic fatty liver disease and alcoholic liver disease, screening for hereditary hemochromatosis, autoimmune hepatitis, Wilson's disease, and alpha-1 antitrypsin deficiency. In addition, a history of prescribed and over-the-counter medicines should be sought. For the evaluation of an alkaline phosphatase elevation determined to be of hepatic origin, testing for primary biliary cholangitis and primary sclerosing cholangitis should be undertaken. Total bilirubin elevation can occur in either cholestatic or hepatocellular diseases. Elevated total serum bilirubin levels should be fractionated to direct and indirect bilirubin fractions and an elevated serum conjugated bilirubin implies hepatocellular disease or biliary obstruction in most settings. A liver biopsy may be considered when serologic testing and imaging fails to elucidate a diagnosis, to stage a condition, or when multiple diagnoses are possible.
引用
- Kwo PY, Cohen SM, Lim JK, et al. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2016. PMID: 27995906. doi:10.1038/ajg.2016.517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。